Pharmact at a Glance

Pharmact is a medtech company focusing on preventing disease through early detection. The company’s international team of medical experts provides healthcare professionals with qualitative point-of-care rapid tests for the early detection of chronic diseases such as type 2 diabetes mellitus and liver fibrosis, as well as acute myocardial infarction.

To help tackle the COVID-19 global pandemic, Pharmact has developed a highly sensitive and accurate antibody test. The BELTEST-IT COV-2 Rapid Test is an immunochromatographic test for the qualitative detection of immunoglobins M (IgM) and G (IgG) against the SARS-CoV-2 virus in human whole blood and serum. The test assists in determining possible immune reaction against coronavirus infection.

Pharmact’ s most recent project currently under development, is a revolutionary drug that combats arteriosclerosis. An international board of trustees supports its development.

Founded in Berlin, Pharmact’ s international distribution headquarters is located at CUBEX 41, the innovative center for medtech start-ups based on the University Hospital Mannheim campus. The company is operated in the United States by Pharmact Healthcare Inc. in Chapel Hill, North Carolina.

0
Founded
0
Partners Worldwide
0
Countries

OUR VISION

A world free from chronic disease.

OUR MISSION

We are committed to improving the health of the global community through the early diagnosis of chronic disease.

OUR CORE VALUES

Commitment. Passion. Integrity. Empathy. Respect.